George Kemble
Presidente presso SAGIMET BIOSCIENCES INC.
Patrimonio netto: 833 505 $ in data 31/05/2024
Posizioni attive di George Kemble
Società | Posizione | Inizio | Fine |
---|---|---|---|
SAGIMET BIOSCIENCES INC. | Presidente | 24/10/2022 | - |
Direttore/Membro del Consiglio | 01/10/2015 | 24/10/2022 | |
Amministratore Delegato | 01/10/2015 | 24/10/2022 | |
Direttore Tecnico/Scientifico/R&S | 15/08/2011 | 24/10/2022 | |
Presidente | 01/10/2015 | 24/10/2022 |
Storia della carriera di George Kemble
Precedenti posizioni note di George Kemble
Società | Posizione | Inizio | Fine |
---|---|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Direttore Tecnico/Scientifico/R&S | - | - |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | - | - |
LigoCyte Pharmaceuticals, Inc. | Direttore/Membro del Consiglio | 29/01/2010 | - |
Formazione di George Kemble
Santa Clara University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SAGIMET BIOSCIENCES INC. | Health Technology |
Aziende private | 3 |
---|---|
LigoCyte Pharmaceuticals, Inc. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Health Technology |
- Borsa valori
- Insiders
- George Kemble
- Esperienza